Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Windlas Biotech secures EU GMP approval for Dehradun Plant-IV with zero critical observations Windlas Biotech’s Dehradun Plant-IV earns EU GMP approval with zero critical observations, unlocking new opportunities in European regulated markets. bySrinathApril 15, 2022